BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30886504)

  • 1. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
    Yu MM; Feng YH; Zheng L; Zhang J; Luo GH
    World J Gastroenterol; 2019 Mar; 25(10):1210-1223. PubMed ID: 30886504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation.
    Wang X; Li Y; Fang Z; Li Y
    Bioengineered; 2021 Dec; 12(2):12204-12214. PubMed ID: 34783304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the proteasome-dependent degradation of ISGylated p53.
    Ren Y; Yang J; Ding Z; Zheng M; Qiu L; Tang A; Huang D
    Cancer Sci; 2023 Sep; 114(9):3523-3536. PubMed ID: 37350063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of LncRNA-HOST2 on cell proliferation, migration, invasion and apoptosis of human hepatocellular carcinoma cell line SMMC-7721.
    Liu RT; Cao JL; Yan CQ; Wang Y; An CJ; Lv HT
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.
    Gao J; Ding F; Liu Q; Yao Y
    Mol Cell Biochem; 2013 Apr; 376(1-2):21-32. PubMed ID: 23232575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Asano T; Yamada S; Fuchs BC; Takami H; Hayashi M; Sugimoto H; Fujii T; Tanabe KK; Kodera Y
    Int J Oncol; 2017 May; 50(5):1647-1654. PubMed ID: 28350091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of acid-sensing ion channel 1α in hepatic carcinoma cell migration and invasion.
    Jin C; Ye QH; Yuan FL; Gu YL; Li JP; Shi YH; Shen XM; Bo-Liu ; Lin ZH
    Tumour Biol; 2015 Jun; 36(6):4309-17. PubMed ID: 25613068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition.
    Lv G; Tan Y; Lv H; Fang T; Wang C; Li T; Yu Y; Hu C; Wen W; Wang H; Yang W
    Sci China Life Sci; 2017 Nov; 60(11):1203-1213. PubMed ID: 28812296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma.
    Dai B; Zhang X; Shang R; Wang J; Yang X; Zhang H; Liu Q; Wang D; Wang L; Dou K
    Cell Commun Signal; 2018 Dec; 16(1):99. PubMed ID: 30545369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang Y; Liu Q; Zhang H; Zhao H; Mao R; Li Z; Ya S; Jia C; Bao Y
    Oncol Rep; 2017 Feb; 37(2):1182-1188. PubMed ID: 28075476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFE2L3 promotes malignant behavior and EMT of human hepatocellular carcinoma (HepG2) cells via Wnt/β‑catenin pathway.
    Ren Y; Wang Y; Hao S; Yang Y; Xiong W; Qiu L; Tao J; Tang A
    J Cancer; 2020; 11(23):6939-6949. PubMed ID: 33123284
    [No Abstract]   [Full Text] [Related]  

  • 20. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.